Types of Weight Loss Surgery Procedures
The right weight loss surgery for you depends on many factors, including your weight, age, medical conditions and past operations. We offer a number of weight loss surgery options, including:
- Gastric bypass: creating a small stomach pouch connected to the small intestine in a “Roux-en-Y” fashion
- Sleeve gastrectomy: creating a smaller stomach by removing the outer portion of your stomach
- Revisions to a previous weight loss surgery (such as an adjustable Lap-Band® surgery)
- VBLOC Therapy procedure
Weight loss surgery reduces the size of the stomach and alters mechanisms that control hunger and some of your digestion. It also limits the amount of food you can eat and digest at one time. Most patients feel full and satisfied with eating smaller portions. These effects empower patients to lose significant amounts of weight and maintain that weight loss. With the proper guidance of our team and nutritionists, you will get the nutrition and vitamins you need for good health.
New devices are essential to keeping innovation in the United States and to help us meet the needs of patients with obesity. VBLOC represents an innovative, new approach to the treatment of obesity. VBLOC works by blocking signals along the nerves that connect the brain and stomach, reducing feelings of hunger and promoting earlier feelings of fullness. This is helpful for people with obesity to reduce their calorie intake, and promote safe, healthy, and durable weight loss.
VBLOC therapy doesn't surgically change or restrict the digestive system, does not prevent absorption of nutrients, and is a reversible treatment which allows patients to lose weight by a new mechanism. It can be adjusted, deactivated, reactivated or completely removed if desired. It is delivered through the Maestro® Rechargeable System, a pacemaker-like implant, and is non-invasively programmed by a physician to best meet the individual patient’s needs. The implantation of the Maestro® System does not change normal digestive system structure and allows for a normal diet and lifestyle.
Patients choosing not to pursue surgery may be interested in this novel technology. The Maestro® Rechargeable System has received Food and Drug Administration (FDA) approval as well as CE Mark in Europe, and has been listed on the Australian Register of Therapeutic Goods (ARTG) by the Therapeutic Goods Administration (TGA) for supply in Australia. The FDA approved the Maestro device for use in patients 18 years and older who have a body mass index (BMI) of 35 to 45 and at least one other obesity-related condition, such as type 2 diabetes. Candidates for the device must also have failed at least one supervised weight management program within the past five years.
For more information, read the FDA press release.